Tags |
|
|
Links |
|
|
Main Subject - Negotiating with Unions to Take Pay Severance Packages
Any high-ranking corporate top executive will tell you that nego
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
tiating with the unions is no easy matter and if it is not done
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
correctly it causes a rift between management and labor and can
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
disrupt the company for years to come. In this case, it is usua
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ly the management that must go, as the union generally stays int
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
act because without labor you cannot run your business.
But how
But how
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
do you negotiate with labor unions? Currently we see at Ford M
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
tor Co. an offer of a pretty decent severance package to some 70
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
,000 employees to take early retirement. Meanwhile Ford Motor Co
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
. has announced last year that it will layoff 300,000 people wit
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
in the next four years. Currently they are letting go 14,500 pe
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ople and in doing so that does give the upper hand to Ford Motor
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
Co. in negotiating with the unions and getting employees to tak
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
e the severance pay packages.
One union boss who was familiar w
One union boss who was familiar w
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
th the plant closings and the layoffs said that Ford Motor Co. w
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
as indeed offering them a pretty good package and for many emplo
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
yees it might be wise for them to take it. It is amazing when yo
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
can have a union boss state such in a major financial world new
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
spaper. It shows that Ford Motor Co. has indeed done a very goo
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
d job negotiating with its unions. Please consider this in 2006
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/31212/mainsubjects-Negotiating-with-Unions-to-Take-Pay-Severance-Packages.html">Negotiating with Unions to Take Pay Severance Packages</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/31212/mainsubjects-Negotiating-with-Unions-to-Take-Pay-Severance-Packages.html]Negotiating with Unions to Take Pay Severance Packages[/url]
Related Articles:
Medical Billing - Doctor Files Overview
Direct Deposit of Employee Wages
Whom Do You Invite to a Meeting?
Bookmark it:
|